Literature DB >> 9760391

A case study of the evolving software architecture for the FDA generic drug application process.

K Canfield1, M Ritondo, R Sponaugle.   

Abstract

This primary goal of this project was to develop a software architecture to support the Food and Drug Administration (FDA) generic drug application process by making it more efficient and effective. The secondary goal was to produce a scalable, modular, and flexible architecture that could be generalized to other contexts in interorganizational health care communications. The system described here shows improvements over the old system for the generic drug application process for most of the defined design objectives. The modular, flexible design that produced this new system offers lessons for the general design of distributed health care information systems and points the way to robust application frameworks that will allow practical development and maintenance of a distributed infrastructure.

Mesh:

Substances:

Year:  1998        PMID: 9760391      PMCID: PMC61324          DOI: 10.1136/jamia.1998.0050432

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  2 in total

Review 1.  Comparing middleware concepts for advanced healthcare system architectures.

Authors:  B Blobel; M Holena
Journal:  Int J Med Inform       Date:  1997-09       Impact factor: 4.046

2.  Internet-based support for bioscience research: a collaborative genome center for human chromosome 12.

Authors:  P L Miller; P M Nadkarni; K K Kidd; K Cheung; D C Ward; A Banks; P Bray-Ward; L Cupelli; V Herdman; I Marondel; K Montgomery; B Renault; S J Yoon; K S Krauter; R Kucherlapati
Journal:  J Am Med Inform Assoc       Date:  1995 Nov-Dec       Impact factor: 4.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.